Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity.

Yu R, Gollub RL, Vangel M, Kaptchuk T, Smoller JW, Kong J.

Hum Brain Mapp. 2014 Sep;35(9):4583-93. doi: 10.1002/hbm.22496. Epub 2014 Feb 27.

2.

Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation.

Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P, Puls I, Sander T, Heinz A, Gallinat J.

Neuroimage. 2008 Oct 1;42(4):1631-8. doi: 10.1016/j.neuroimage.2008.06.019. Epub 2008 Jun 25.

PMID:
18634888
3.

Hypnotic susceptibility modulates brain activity related to experimental placebo analgesia.

Huber A, Lui F, Porro CA.

Pain. 2013 Sep;154(9):1509-18. doi: 10.1016/j.pain.2013.03.031. Epub 2013 Mar 28.

PMID:
23664683
4.

Mindfulness Meditation-Based Pain Relief Employs Different Neural Mechanisms Than Placebo and Sham Mindfulness Meditation-Induced Analgesia.

Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG, Coghill RC.

J Neurosci. 2015 Nov 18;35(46):15307-25. doi: 10.1523/JNEUROSCI.2542-15.2015.

5.

Neural bases of conditioned placebo analgesia.

Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA.

Pain. 2010 Dec;151(3):816-24. doi: 10.1016/j.pain.2010.09.021. Epub 2010 Oct 12.

PMID:
20943318
6.

Effective connectivity predicts future placebo analgesic response: A dynamic causal modeling study of pain processing in healthy controls.

Sevel LS, O'Shea AM, Letzen JE, Craggs JG, Price DD, Robinson ME.

Neuroimage. 2015 Apr 15;110:87-94. doi: 10.1016/j.neuroimage.2015.01.056. Epub 2015 Feb 3.

7.

Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.

Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ.

PLoS One. 2012;7(10):e48135. doi: 10.1371/journal.pone.0048135. Epub 2012 Oct 23.

8.

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D.

Science. 2003 Feb 21;299(5610):1240-3.

9.

Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.

Hori H, Fujii T, Yamamoto N, Teraishi T, Ota M, Matsuo J, Kinoshita Y, Ishida I, Hattori K, Okazaki M, Arima K, Kunugi H.

J Psychiatr Res. 2014 Sep;56:82-9. doi: 10.1016/j.jpsychires.2014.05.006. Epub 2014 May 20.

PMID:
24888672
10.

Catechol-O-methyltransferase (COMT) influences the connectivity of the prefrontal cortex at rest.

Tunbridge EM, Farrell SM, Harrison PJ, Mackay CE.

Neuroimage. 2013 Mar;68:49-54. doi: 10.1016/j.neuroimage.2012.11.059. Epub 2012 Dec 7.

11.

The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli.

Loggia ML, Jensen K, Gollub RL, Wasan AD, Edwards RR, Kong J.

PLoS One. 2011;6(11):e27764. doi: 10.1371/journal.pone.0027764. Epub 2011 Nov 21.

12.

Genetic contribution of catechol-O-methyltransferase in hippocampal structural and functional changes of female migraine sufferers.

Liu J, Lan L, Mu J, Zhao L, Yuan K, Zhang Y, Huang L, Liang F, Tian J.

Hum Brain Mapp. 2015 May;36(5):1782-95. doi: 10.1002/hbm.22737. Epub 2015 Jan 19.

PMID:
25598522
13.

Are there sex differences in placebo analgesia during visceral pain processing? A fMRI study in healthy subjects.

Theysohn N, Schmid J, Icenhour A, Mewes C, Forsting M, Gizewski ER, Schedlowski M, Elsenbruch S, Benson S.

Neurogastroenterol Motil. 2014 Dec;26(12):1743-53. doi: 10.1111/nmo.12454. Epub 2014 Oct 23.

14.

The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response.

Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC.

J Neurosci. 2009 Apr 15;29(15):4882-7. doi: 10.1523/JNEUROSCI.5634-08.2009.

15.

Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.

Lo Bianco L, Blasi G, Taurisano P, Di Giorgio A, Ferrante F, Ursini G, Fazio L, Gelao B, Romano R, Papazacharias A, Caforio G, Sinibaldi L, Popolizio T, Bellantuono C, Bertolino A.

Psychol Med. 2013 Feb;43(2):279-92. doi: 10.1017/S0033291712001134. Epub 2012 May 23.

PMID:
22617427
17.

Distinct neural representations of placebo and nocebo effects.

Freeman S, Yu R, Egorova N, Chen X, Kirsch I, Claggett B, Kaptchuk TJ, Gollub RL, Kong J.

Neuroimage. 2015 May 15;112:197-207. doi: 10.1016/j.neuroimage.2015.03.015. Epub 2015 Mar 14.

18.

An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects.

Benjamin J, Osher Y, Lichtenberg P, Bachner-Melman R, Gritsenko I, Kotler M, Belmaker RH, Valsky V, Drendel M, Ebstein RP.

Neuropsychobiology. 2000;41(1):48-53.

PMID:
10629435
19.

Aversive stimuli lead to differential amygdala activation and connectivity patterns depending on catechol-O-methyltransferase Val158Met genotype.

Rasch B, Spalek K, Buholzer S, Luechinger R, Boesiger P, de Quervain DJ, Papassotiropoulos A.

Neuroimage. 2010 Oct 1;52(4):1712-9. doi: 10.1016/j.neuroimage.2010.05.054. Epub 2010 May 25.

PMID:
20510373
20.

Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation.

Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR.

Arch Gen Psychiatry. 2006 Dec;63(12):1396-406.

PMID:
17146014
Items per page

Supplemental Content

Write to the Help Desk